Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure.
about
Ixabepilone as monotherapy or in combination for the treatment of advanced breast cancer.A phase II study of gemcitabine plus paclitaxel in patients with metastatic breast cancer and prior anthracycline treatment.Primary systemic therapy with intermittent weekly paclitaxel plus gemcitabine in patients with stage II and III breast cancer: a phase II trial.Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer.
P2860
Phase II study of gemcitabine plus paclitaxel in metastatic breast cancer patients with prior anthracycline exposure.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Phase II study of gemcitabine ...... prior anthracycline exposure.
@en
Phase II study of gemcitabine ...... prior anthracycline exposure.
@nl
type
label
Phase II study of gemcitabine ...... prior anthracycline exposure.
@en
Phase II study of gemcitabine ...... prior anthracycline exposure.
@nl
prefLabel
Phase II study of gemcitabine ...... prior anthracycline exposure.
@en
Phase II study of gemcitabine ...... prior anthracycline exposure.
@nl
P2093
P2860
P356
P1433
P1476
Phase II study of gemcitabine ...... prior anthracycline exposure.
@en
P2093
Ender Kurt
Guzin Gonullu
Ismet Tasdelen
Murat Arslan
Mutlu Demiray
Osman Manavoglu
Ozkan Kanat
Ozlem Saraydaroglu
Sahsine Tolunay
Sehsuvar Gokgoz
P2860
P304
P356
10.1081/CNV-67133
P50
P577
2005-01-01T00:00:00Z